KOL

KOL (Key Opinion Leaders)

speaker

KOL Engagement and Panning, KOL Opinion, KOL Insights Primary Market Research, Rare Disease Research & Knowledge

Thelansis has strong expertise in identifying, mapping, segmenting, and profiling of KOLs across therapy areas to collect most relevant KOL Insights/ KOL Opinion. KOL engagement right from the beginning of the product development process is the key success factor in Rare and ultra-rare indications. Global KOL Panel Management System; comprises directories of trial investigators, Researcher, Healthcare Practitioner (HCPs), Payers, Regulatory bodies, and speakers

Successful KOL identification is about identifying anyone with the potential to impact your work – clinicians, authors, speakers, nurses, tweeters, or the medics building cutting edge apps for their patients.

We’re confident in our ability & accuracy to identify the right people because we’ve spent years engineering every step of the KOL identification process and transforming what ‘KOL identification’ can do for you.

We also appreciate that our work is all about people. That’s why even the largest bucket of objective analytics in the world cannot circumvent the subjective nuances of KOL identification and influence.

So, whether your KOL identification requires a global programme, a national exercise, or an exploration of the emerging markets of tomorrow – we can help.

Because KOL identification is what we do, every single day.

KOL mapping involves mapping the entire Expert/KOL landscape as a whole — essential because you can’t validate an individual Expert in isolation of their peer group, or without consideration of the overall context.

KOL mapping can also map the entire “KOL pyramid” — essential to help you identify, understand, and engage with every single segmented layer — each with its own requirements.

But beware — the KOL pyramid identified through KOL mapping today, say a few of years pre-launch, is not going to be the same one as you get to launch. The pyramid often “flips” so that the front-line HCPs who were at the lower rungs of the original pyramid now rise to the top as they become your most important customers and new KOLs. These are people who will now impact the uptake of your medicine post-launch.

Our on-going systematic and analytical KOL mapping programmes can help map all of this.

Our KOL mapping can also help you to see the connections, collaborations, and networks that exist within a community of Experts, giving you a complete contextual picture of the Expert/KOL landscape — a canvas on which to create your own unique KOL programmes.

When you know your KOLs well, all you may need is an unbiased sense-check to quickly and efficiently validate your current list.

Similarly, when you have been in a therapy area for a while, you may get used to working with the same people over and over again. So, you don’t always see the changes happening just outside your field of vision — the myopia of over-confidence and over-familiarity creeps in.

That’s where KOL validation can help.

You give us a list of KOLs, and we’ll augment, segment, refresh, and validate from multiple angles, involving multiple research methodologies.

Our KOL validation can tell you the three most important things you need to know — who should stay, who should go, who new to add — to help keep your KOL lists fully up-to-date and entirely pertinent to your strategic and tactical needs.

Beyond the top KOLs, who are the rising stars, the emerging Experts? And what about the more distant “faint signals” — the people you should be actively looking for?

And by rising stars we don’t just mean clinicians. Even a newly active youtuber in a rare disease represents an emerging Expert – someone who should definitely be on your radar.

Identifying, mapping, and keeping track of the future emerging Experts and rising stars is never easy — things change, ideas wax and wane, people come and go…

Yet given the extended development cycle of medicines and devices, the importance of identifying, understanding, and engaging rising stars, emerging Experts, and the next generation of KOLs is clear.

We have the processes, methodologies, and patience to help you identify rising stars and see beyond the present so that when the future does come, you are completely prepared for it.

With different patterns of communication and engagement, digital KOLs are a different breed altogether requiring a whole new set of methodologies & tools with which to identify and map.

To start with, digital KOLs require you to go beyond simple identification and look at more advanced segmentation and phenotyping based on an individual’s digital characteristics and propensity for online interactions (e.g. data multiplier, content creator, opinion former, proactive educator, etc).

Analysing digital KOL mindset is also important when creating engagement plans — what is their online view on key therapeutic issues, what topics within your therapy area are they most vocal about online?

And finally, given the dynamic nature of the online realm, it’s essential to activate real-time monitoring of key influencer activity to help identify acute opportunities for digital KOLs in discussions happening on-line.

Our range of digital KOL services help you navigate all the above facets of this brave new world —identification, analytics, segmentation, phenotyping, mindset, influencer monitoring, digital KOL landscape mapping — without forgetting that the traditional underlying principles of thought leadership, Expertise, and human influence still apply.

Collaborative groups, co-operative groups, clinical trial groups, clinical collectives – known by many different names, the importance of such groups in designing, supporting, and running clinical trial programmes is in no doubt.

We can help you identify, map, and understand the Co-operative Group landscape with un-paralleled detail. Who are the most important groups, which indications and molecules are they focussing on, what practice-changing trials have they been responsible for?

Our profiles give you all the details you need to monitor, segment, and prioritise your Co-operative Group engagements – disease state activity, study type metrics, study phase analysis, drugs investigated, collaborations with KOLs, publications and other outputs, trialists and collaborators involved, and much more.

A “stakeholder” is simply any entity or voice with the power to impact the success of your medicine. And effective stakeholder mapping helps you take a holistic approach to stakeholder engagement.

Stakeholder mapping gives you:
The people — KOLs, Nurse Practitioners, Patient Advocates, Regional Experts, Physicians, Speakers…

The places — Centres of Excellence, Treatment Centres, Trial Centres, Referral Centres…

The organisations — Professional Medical Organisations, Patient Organisations, Advocacy Groups, Payor Groups, Independent Funding Bodies, NGOs…

Stakeholder mapping ensure that all your stakeholders, influencers, networks, and voices are all identified, mapped, and profiled, all in one place.

Our speaker mapping service can help you optimise your identification and selection of speakers to meet all your strategic and communication needs.

To identify, profile, and give you the most comprehensive and accurate speaker map possible, our speaker mapping service involves multiple research methodologies that include speaker activity analysis, audience research, and 1-to-1 discussions with leading speakers themselves.

We curate all these inputs to map the speaker landscape and make solid recommendations that you can feel completely confident about.

Speaker mapping gives you all the insights (and digital tools) you need to understand the speaker landscape, assemble a group of powerful speakers, and consistently select the right speaker for your topics, audiences, and events.

Our speaker mapping service hands all of this to you on a plate, driven by evidence, with the highest level of compliance and confidence.

A small treatment centre that’s pioneering the use of a relatively new diagnostic biomarker may not be a traditional “centre of excellence”, but it may be a centre of importance to your success.

Likewise, a particular fellowship training programme may not be the world’s most renowned “centre of excellence” but the emerging Experts coming out of that centre, all sharing the same thinking and approach to management, may be important to your work.

Going beyond centre of excellence mapping, we can tell you about a wide range of important institutions — clinical trial sites, tertiary referral centres, primary-care management groups in sparsely populated regions, R&D powerhouses, hospitals with a focus on technology.

Identifying and mapping all such centres also requires us to go beyond traditional identification methods such as those used when mapping more established centres of excellence because these tend to have traits that are easily identifiable and quantifiable e.g. analysing high-value publication outputs, looking for the presence of KOLs, assessing established reputations, etc.